|
Attention-Deficit Hyperactivity Disorder Market ForecastPublished by: Datamonitor Published: Jul. 3, 2009 - 119 Pages Table of Contents
AbstractIntroductionDriven primarily by continued uptake of Shire's market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. Ongoing uptake of Shire's Vyvanse (lisdexamfetamine), was also a key contributor to market growth between 2007 and 2008. Reasons to Purchase
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||